Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metastatic bone disease: Pathogenesis and therapeutic options
Stella D’Oronzo, Robert E. Coleman, Janet E. Brown, et al.
Journal of bone oncology (2018) Vol. 15, pp. 100205-100205
Open Access | Times Cited: 214

Showing 1-25 of 214 citing articles:

Bone health in cancer: ESMO Clinical Practice Guidelines
Robert E. Coleman, Peyman Hadji, Jean‐Jacques Body, et al.
Annals of Oncology (2020) Vol. 31, Iss. 12, pp. 1650-1663
Open Access | Times Cited: 370
Extracellular Matrix Alterations in Metastatic Processes
Mayra Paolillo, Sergio Schinelli
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4947-4947
Open Access | Times Cited: 312
The Regulation of Bone Metabolism and Disorders by Wnt Signaling
Kazuhiro Maeda, Yasuhiro Kobayashi, Masanori Koide, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5525-5525
Open Access | Times Cited: 278
Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Stefan Zöllner, James F. Amatruda, Sebastian Bauer, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1685-1685
Open Access | Times Cited: 178
Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders
Rexhina Vlashi, Xingen Zhang, Mengrui Wu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1291-1317
Open Access | Times Cited: 78
Molecular mechanisms and clinical management of cancer bone metastasis
Manni Wang, Fan Xia, Yuquan Wei, et al.
Bone Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 117
Evolving cancer–niche interactions and therapeutic targets during bone metastasis
Robert L. Satcher, Xiang H.-F. Zhang
Nature reviews. Cancer (2021) Vol. 22, Iss. 2, pp. 85-101
Open Access | Times Cited: 87
Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment
Afshin Moradi, Srilakshmi Srinivasan, Judith A. Clements, et al.
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 3, pp. 333-346
Closed Access | Times Cited: 86
The Endosteal Niche in Breast Cancer Bone Metastasis
Marie‐Therese Haider, Daniel J. Smit, Hanna Taipaleenmäki
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 71
Mechanisms, Diagnosis and Treatment of Bone Metastases
Jozef Ban, Valerie Fock, Dave N.T. Aryee, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2944-2944
Open Access | Times Cited: 63
Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer
Mengmeng Long, Xuemeng Liu, Xu Huang, et al.
Journal of Controlled Release (2021) Vol. 334, pp. 303-317
Closed Access | Times Cited: 59
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications
Cinzia Baldessari, Stefania Pipitone, Eleonora Molinaro, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1518-1518
Open Access | Times Cited: 23
Epidemiology of spinal cord and column tumors
Joshua T. Wewel, John E. O’Toole
Neuro-Oncology Practice (2020) Vol. 7, Iss. Supplement_1, pp. i5-i9
Open Access | Times Cited: 66
From latency to overt bone metastasis in breast cancer: potential for treatment and prevention
Fernando Salvador, Alicia Llorente Lope, Roger R. Gomis
The Journal of Pathology (2019) Vol. 249, Iss. 1, pp. 6-18
Open Access | Times Cited: 59
Molecular Imaging of Bone Metastases and Their Response to Therapy
Gary Cook, Vicky Goh
Journal of Nuclear Medicine (2020) Vol. 61, Iss. 6, pp. 799-806
Open Access | Times Cited: 57
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
Malene Grubbe Hildebrandt, Mohammad Naghavi‐Behzad, Marianne Vogsen
Seminars in Nuclear Medicine (2022) Vol. 52, Iss. 5, pp. 520-530
Open Access | Times Cited: 36
Expression Profiling of Selected Immune Genes and Trabecular Microarchitecture in Breast Cancer Skeletal Metastases Model: Effect of α–Tocopherol Acetate Supplementation
Riadh Badraoui, Mοhd Saeed, Nouha Bouali, et al.
Calcified Tissue International (2022) Vol. 110, Iss. 4, pp. 475-488
Closed Access | Times Cited: 32
Deep learning–based algorithm improved radiologists’ performance in bone metastases detection on CT
Shunjiro Noguchi, Mizuho Nishio, Ryo Sakamoto, et al.
European Radiology (2022) Vol. 32, Iss. 11, pp. 7976-7987
Closed Access | Times Cited: 32
The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
Yanzhao Dong, Haiying Zhou, Ahmad Alhaskawi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1193-1193
Open Access | Times Cited: 21
Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
Linda Cucciniello, Giovanna Garufi, Rossana Di Rienzo, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102624-102624
Open Access | Times Cited: 19
Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management
Lisa M. Gudenkauf, S. Gray, Brian D. Gonzalez, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 7
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Yujing Guan, Wei Zhang, Yuling Mao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis
Nour Arakil, Shahid Akhtar Akhund, Basant Elaasser, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1075-1075
Open Access | Times Cited: 6
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group
Janet E. Brown, Catherine Handforth, Juliet Compston, et al.
Journal of bone oncology (2020) Vol. 25, pp. 100311-100311
Open Access | Times Cited: 49
Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
Annette Gilchrist, Stephanie Lourdes Echeverria
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top